Tisotumab vedotin Completed Phase 2 Trials for Non-Small Cell Lung Carcinoma (NSCLC) / Oesophagus Cancer / Prostate Cancer / Ovarian Cancer / Endometrial Cancer / Squamous Cell Carcinoma of the Head and Neck (SCCHN) / Cervix Cancer / Bladder Cancer, Cancer Treatment